Gene Page: MYO9A
Summary ?
| GeneID | 4649 |
| Symbol | MYO9A |
| Synonyms | - |
| Description | myosin IXA |
| Reference | MIM:604875|HGNC:HGNC:7608|Ensembl:ENSG00000066933|HPRD:05341|Vega:OTTHUMG00000133440 |
| Gene type | protein-coding |
| Map location | 15q22-q23 |
| Pascal p-value | 0.02 |
| Sherlock p-value | 0.185 |
| eGene | Cerebellar Hemisphere |
Gene in Data Sources
| Gene set name | Method of gene set | Description | Info |
|---|---|---|---|
| CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
| Top 10 positively co-expressed genes | ||
| Gene | Pearson's Correlation | Spearman's Correlation |
| CLTC | 0.87 | 0.84 |
| YWHAB | 0.86 | 0.83 |
| NDFIP1 | 0.86 | 0.84 |
| PPP1R2 | 0.86 | 0.84 |
| MORF4L2 | 0.86 | 0.85 |
| NDEL1 | 0.85 | 0.83 |
| GPRASP2 | 0.85 | 0.80 |
| SERINC1 | 0.85 | 0.82 |
| ITFG1 | 0.85 | 0.83 |
| UBLCP1 | 0.85 | 0.86 |
| Top 10 negatively co-expressed genes | ||
| Gene | Pearson's Correlation | Spearman's Correlation |
| MT-CO2 | -0.65 | -0.52 |
| AF347015.21 | -0.65 | -0.46 |
| AF347015.2 | -0.64 | -0.50 |
| AF347015.8 | -0.63 | -0.50 |
| AF347015.33 | -0.62 | -0.48 |
| MT-CYB | -0.61 | -0.48 |
| AF347015.26 | -0.61 | -0.47 |
| FXYD1 | -0.60 | -0.48 |
| AF347015.31 | -0.60 | -0.49 |
| AF347015.18 | -0.60 | -0.49 |
Section V. Pathway annotation
| Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
|---|---|---|---|
| RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED DN | 805 | 505 | All SZGR 2.0 genes in this pathway |
| GRAESSMANN APOPTOSIS BY DOXORUBICIN DN | 1781 | 1082 | All SZGR 2.0 genes in this pathway |
| HAMAI APOPTOSIS VIA TRAIL UP | 584 | 356 | All SZGR 2.0 genes in this pathway |
| SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN UP | 479 | 299 | All SZGR 2.0 genes in this pathway |
| BUYTAERT PHOTODYNAMIC THERAPY STRESS UP | 811 | 508 | All SZGR 2.0 genes in this pathway |
| BENPORATH SOX2 TARGETS | 734 | 436 | All SZGR 2.0 genes in this pathway |
| ZHENG FOXP3 TARGETS IN THYMUS UP | 196 | 137 | All SZGR 2.0 genes in this pathway |
| ACEVEDO METHYLATED IN LIVER CANCER DN | 940 | 425 | All SZGR 2.0 genes in this pathway |
| GABRIELY MIR21 TARGETS | 289 | 187 | All SZGR 2.0 genes in this pathway |
| FORTSCHEGGER PHF8 TARGETS DN | 784 | 464 | All SZGR 2.0 genes in this pathway |